Aim and objective: To study the psychiatric morbidity among transgender population.
Materials and methods: A cross-sectional study was done using convenience sampling. Sixty consenting transgenders, fulfilling criteria for gender dysphoria based on DSM-5 criteria, were included. The study was done for a period of 18 months.
Tools used: For assessing the sociodemographic profile, semi-structured pro forma was used, and for assessing psychiatric morbidities, Mini International Neuropsychiatric Interview (MINI)-plus scale was used.
Results: Among 60 participants, 36 (76.6%) had psychiatric morbidity, of which 16 (26.7%) had substance-use disorder, 10 (16.7%) among them had alcohol dependence, and 6 (10%) had nonalcoholic substance-use disorders, such as cannabis, benzodiazepines, and cocaine.
Ten (16.7%) participants qualified for the diagnosis of depressive disorder among which six (10%) had mild depression and four (6.7%) had moderate depression. Dysthymia was present in four (6.6%) individuals. Eleven (18.3%) participants had adjustment disorder. Three (5%) of them had anxiety disorder and two (3.3%) had insomnia.
Conclusion: Substance use and depression were found to be the most common psychiatric disorders among this population followed by adjustment disorders.
As this population is at higher risk of developing other psychiatric problems, regular screening and timely intervention are needed to prevent or treat their psychiatric comorbidities.
Clinical significance: The study highlights that there are various psychiatric morbidities prevalent among transgender population, mainly due to the various life adversities they face, which points toward encouraging and creating awareness toward the need for reducing discrimination and accepting the transgender persons in the families, friends, and the community groups which will help them in mainstreaming, achieve welfare, and reduce their psychosocial problems.
The findings of this study may help to inform the development of appropriately targeted and tailored mental health interventions and resilience-building programs for transgender population.
American Psychological Association. Guidelines for psychological practice with transgender and gender nonconforming people. Am Psychol 2015;70(9):832–864. DOI: 10.1037/a0039906.
World Health Organization. The ICD-10 classification of mental and behavioural disorders. 10th ed. 1992.
Census of India 2011. Available from: http://www.imaginmor.com/census-of-india-2011.html [Last accessed on November 21, 2021].
Richards C, Bouman WP, Seal L, et al. Non-binary or genderqueer genders. Int Rev Psychiatry 2016;28(1):95–102. DOI: 10.3109/09540261.2015.1106446.
Okabe N, Sato T, Matsumoto Y, et al. Clinical characteristics of patients with gender identity disorder at a Japanese gender identity disorder clinic. Psychiatry Res 2008;157(1–3):315–318. DOI: 10.1016/j.psychres.2007.07.022.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl 20):22–33. PMID: 9881538.
Bariola E, Lyons A, Leonard W, et al. Demographic and psychosocial factors associated with psychological distress and resilience among transgender individuals. Am J Public Health 2015;105(10):2108–2116. DOI: 10.2105/AJPH.2015.302763.
Conron KJ, Scott G, Stowell GS, et al. Transgender health in Massachusetts: results from a household probability sample of adults. Am J Public Health 2012;102(1):118–122. DOI: 10.2105/AJPH.2011.300315.
Fredriksen-Goldsen KI, Cook-Daniels L, Kim H-J, et al. Physical and mental health of transgender older adults: an at-risk and underserved population. Gerontologist 2013;54(3):488–500. DOI: 10.1093/geront/gnt021.
Grant J, Mottet L, Tanis J, et al. National transgender discrimination survey report on health and health care findings of a study by the national center for transgender equality and the National Gay and Lesbian Task Force [Internet]. 2010.
Niranjan Hebbar Y, Singh B. Psychiatric morbidity in a selective sample of transgenders in Imphal, Manipur: a descriptive study. Ann Indian Psychiatry 2017;1(2):114. DOI: 10.4103/aip.aip_24_17.
Hoshiai M, Matsumoto Y, Sato T, et al. Psychiatric comorbidity among patients with gender identity disorder. Psychiatry Clin Neurosci 2010;64(5):514–519. DOI: 10.1111/j.1440-1819.2010.02118.x.
Reisner SL, Poteat T, Keatley J, et al. Global health burden and needs of transgender populations: a review. Lancet 2016;388(10042):412–436. DOI: 10.1016/S0140-6736(16)00684-X.
Reisner SL, Biello KB, Hughto JW, et al. Psychiatric diagnoses and comorbidities in a diverse, multicity cohort of young transgender women: baseline findings from project life skills. JAMA Pediatr 2016;170(5):481–486. DOI: 10.1001/jamapediatrics.2016.0067.